Screening for left ventricular dysfunction using a hand-carried cardiac ultrasound device

被引:46
作者
Vourvouri, EC
Schinkel, AFL
Roelandt, JRTC
Boomsma, F
Sianos, G
Bountioukos, M
Sozzi, FB
Rizzello, V
Bax, JJ
Karvounis, HI
Poldermans, D
机构
[1] Erasmus MC, Thoraxctr, NL-3015 GD Rotterdam, Netherlands
[2] Erasmus MC, Dept Intervent Cardiol, NL-3015 GD Rotterdam, Netherlands
[3] Erasmus MC, Dept Cardiol, NL-3015 GD Rotterdam, Netherlands
[4] Erasmus MC, Dept Internal Med, NL-3015 GD Rotterdam, Netherlands
[5] Leiden Med Ctr, Dept Cardiol, Leiden, Netherlands
关键词
left ventricular dysfunction; hand-carried ultrasound device; ultrasound stethoscope; brain natriuretic peptide; inferior vena cava collapse;
D O I
10.1016/S1388-9842(03)00155-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The hand-carried cardiac ultrasound (HCU) device is a recently introduced imaging device, which may be potentially useful in the primary care setting. Aim: To test the screening potential of a HCU for the detection of left ventricular (LV) dysfunction by evaluating LV ejection fraction (LVEF) and inferior vena cava (IVC) collapse. Standard echocardiographic system (SE) and plasma brain natriuretic peptide (BNP) measurements were used as a reference. Methods: Eighty-eight consecutive patients (56 male, aged 59 +/- 12 years) with suspected LV dysfunction were enrolled in the study. The HCU-LVEF was visually estimated and the SE-LVEF was derived by the Simpson's biplane method. A LVEF <40% represented LV dysfunction. An IVC collapse of <50% and BNP levels greater than or equal to15 pmol/l were considered abnormal. The correlation of HCU-LVEF, HCU-IVC and BNP to the SE-LVEF and SE-IVC was analysed independently using 2 x 2 tables. Results: Six patients were excluded because of poor echo images. 19/82 patients had LV dysfunction. The HCU and BNP could identify 17 and 18 out of these 19 patients, respectively. The agreement for LVEF and IVC collapse between SE and HCU was 96% for both parameters. The sensitivity of IVC collapse, HCU-LVEF and BNP in identifying patients with LV dysfunction was 26, 89 and 94%, respectively. Conclusion: A HCU device can reliably be used as a screening tool for LV dysfunction. (C) 2003 European Society of Cardiology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:767 / 774
页数:8
相关论文
共 45 条
[1]  
ALEXANDER JH, 2001, THORAXCENTRE J, V13, P105
[2]   Plasma brain natriuretic peptide concentrations predict survival after acute myocardial infarction [J].
Arakawa, N ;
Nakamura, M ;
Aoki, H ;
Hiramori, K .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996, 27 (07) :1656-1661
[3]   B-type natriuretic peptide predicts sudden death in patients with chronic heart failure [J].
Berger, R ;
Huelsman, M ;
Strecker, K ;
Bojic, A ;
Moser, P ;
Stanek, B ;
Pacher, R .
CIRCULATION, 2002, 105 (20) :2392-2397
[4]   Personal ultrasound imager: Abdominal aortic aneurysm screening [J].
Bruce, CJ ;
Spittell, PC ;
Montgomery, SC ;
Bailey, KR ;
Tajik, AJ ;
Seward, JB .
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 2000, 13 (07) :674-679
[5]   Utility of hand-carried ultrasound devices used by cardiologists with and without significant echocardiographic experience in the cardiology inpatient and outpatient settings [J].
Bruce, CJ ;
Montgomery, SC ;
Bailey, KR ;
Tajik, J .
AMERICAN JOURNAL OF CARDIOLOGY, 2002, 90 (11) :1273-+
[6]  
Cowie MR, 1997, EUR HEART J, V18, P208
[7]   Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care [J].
Cowie, MR ;
Struthers, AD ;
Wood, DA ;
Coats, AJS ;
Thompson, SG ;
PooleWilson, PA ;
Sutton, GC .
LANCET, 1997, 350 (9088) :1349-1353
[8]   Adrenomedullin, endothelin, neuropeptide Y, atrial, brain, and C-natriuretic prohormone peptides compared as early heart failure indicators [J].
Daggubati, S ;
Parks, JR ;
Overton, RM ;
Cintron, G ;
Schocken, DD ;
Vesely, DL .
CARDIOVASCULAR RESEARCH, 1997, 36 (02) :246-255
[9]  
Davie AP, 1996, BRIT MED J, V312, P222
[10]  
Fleiss JL, 1981, STAT METHODS RATES P